Entero Healthcare vs Keimed (Apollo) – Can Entero Be the Titan of Pharma Distribution? скачать в хорошем качестве

Entero Healthcare vs Keimed (Apollo) – Can Entero Be the Titan of Pharma Distribution?

Entero Healthcare Solutions Ltd. is one of the fastest-growing companies in India’s pharma distribution industry. Founded in 2018, the company has already crossed ₹5,000+ Cr revenue in just its 6th year of operations. In Q1 FY26, Entero posted 28% revenue growth, but fell short of its EBITDA margin guidance raising questions about its execution strategy. Despite this, Entero has ambitious plans: targeting 30% growth and 4% EBITDA margins, while aiming to consolidate a largely unorganized distribution sector. But the competition is heating up. One of the biggest players in the space, Keimed (Apollo Group) has announced plans to list by FY27 and merge with Apollo Pharmacy, unlocking massive synergies. 📊 In this video, I cover: • Entero’s business model & hyper-growth journey, • Why margins are under pressure. • Competitive landscape: Entero vs. Keimed (Apollo). • The risks & opportunities in pharma distribution. • Can Entero really become the Titan of Pharma Distribution? The industry is at an inflection point, the next few years could define who dominates. #EnteroHealthcare #Keimed #ApolloPharmacy #PharmaDistribution #Healthcare #IndiaGrowth Disclaimer - I'm not SEBI REGISTERED and please don't take this video as a BUY/SELL RECOMMENDATION. That's it for today. Aryansingh, signing off.